trending Market Intelligence /marketintelligence/en/news-insights/trending/-XhCqJS8Cy0CuX9fO-JU2w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Elanco Animal Health books 2.8% rise in Q2 profit, tightens 2019 guidance

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Elanco Animal Health books 2.8% rise in Q2 profit, tightens 2019 guidance

Elanco Animal Health Inc. said its non-GAAP net income for the second quarter came at 28 cents per share, up year over year from 27 cents.

The S&P Global Market Intelligence consensus normalized EPS estimate for the quarter was 26 cents.

Greenfield, Ind.-based Elanco, which provides animal health products and knowledge services, said its non-GAAP net income totaled $101.6 million, a gain of 2.8% from $98.8 million in the year-earlier period.

Total revenue increased on an annual basis to $781.6 million from $770.2 million.

GAAP net income totaled $35.9 million, or 10 cents per share, compared with a loss of $62.8 million, or a loss of 17 cents per share, in the prior-year period.

Year-to-date through June 30, the company's non-GAAP net income totaled 53 cents per share, a fall from 60 cents per share in the prior-year period.

Non-GAAP net income was $194.5 million, a decline from $219.0 million in the prior-year period.

Year-to-date total revenue amounted to $1.51 billion, comparable to the $1.51 billion also generated in the year-earlier period.

The company's GAAP net income grew 580.8% year over year to $67.4 million, or 18 cents per share, in the year to June 30, from $9.9 million, or 3 cents per share.

In reporting its results, the company said it expects adjusted EPS in the range of $1.04 to $1.10 for the full year, a tightening from previous guidance in the range of $1.02 to $1.12.

The S&P Global Market Intelligence consensus normalized EPS estimate for the full year is $1.09.

The company also expects revenue of $3.00 billion to $3.04 billion for the full year, down from previous guidance of $3.02 billion to $3.08 billion. GAAP EPS for the year is expected to be between 36 cents and 44 cents.